<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(3)</volume><submitter>Romanowska M</submitter><funding>Cancer Research UK</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Psoriasis is one of the most frequent skin diseases world-wide. The disease impacts enormously on affected patients and poses a huge financial burden on health care providers. Several lines of evidence suggest that the nuclear hormone receptor peroxisome proliferator activator (PPAR) beta/delta, known to regulate epithelial differentiation and wound healing, contributes to psoriasis pathogenesis. It is unclear, however, whether activation of PPARbeta/delta is sufficient to trigger psoriasis-like changes in vivo.&lt;h4>Methodology/principal findings&lt;/h4>Using immunohistochemistry, we define the distribution of PPARbeta/delta in the skin lesions of psoriasis. By expression profiling, we confirm that PPARbeta/delta is overexpressed in the vast majority of psoriasis patients. W</pubmed_abstract><journal>PloS one</journal><pagination>e9701</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2838790</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.</pubmed_title><pmcid>PMC2838790</pmcid><pubmed_authors>Romanowska M</pubmed_authors><pubmed_authors>Foerster J</pubmed_authors><pubmed_authors>Palmer CN</pubmed_authors><pubmed_authors>Reilly L</pubmed_authors><pubmed_authors>Gustafsson MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.</name><description>&lt;h4>Background&lt;/h4>Psoriasis is one of the most frequent skin diseases world-wide. The disease impacts enormously on affected patients and poses a huge financial burden on health care providers. Several lines of evidence suggest that the nuclear hormone receptor peroxisome proliferator activator (PPAR) beta/delta, known to regulate epithelial differentiation and wound healing, contributes to psoriasis pathogenesis. It is unclear, however, whether activation of PPARbeta/delta is sufficient to trigger psoriasis-like changes in vivo.&lt;h4>Methodology/principal findings&lt;/h4>Using immunohistochemistry, we define the distribution of PPARbeta/delta in the skin lesions of psoriasis. By expression profiling, we confirm that PPARbeta/delta is overexpressed in the vast majority of psoriasis patients. W</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Mar</publication><modification>2026-04-14T23:16:43.368Z</modification><creation>2019-03-26T23:07:27Z</creation></dates><accession>S-EPMC2838790</accession><cross_references><pubmed>20300524</pubmed><doi>10.1371/journal.pone.0009701</doi></cross_references></HashMap>